⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL50989 | 1.00 | — | — | |
| SCHEMBL27445506 | 1.00 | TP53 (0.44) | — | |
| SCHEMBL14889907 | 1.00 | TP53 (0.44) | — | |
| SCHEMBL50988 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL519940 | 0.97 | — | — | |
| Iodide SCHEMBL990640 | 0.97 | — | — | |
| Water SCHEMBL439514 | 0.97 | — | — | |
| SCHEMBL22164139 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL1007680 | 0.97 | — | — | |
| Water SCHEMBL439515 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11332434-B2 | Synthesis of levomethadone hydrochloride | SAFAEI GHOMI JAVAD (IR) | 2022-05-17 | — | — | US | claimed |
| WO-2020212890-A1 | SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE | SAFAEI GHOMI JAVAD (IR) | 2020-10-22 | — | — | WO | claimed |
| US-20200277250-A1 | SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE | SAFAEI GHOMI JAVAD (IR) | 2020-09-03 | — | — | US | claimed |
| EP-3341354-A1 | SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE OR DEXTROMETHADONE HYDROCHLORIDE AND METHODS FOR USE THEREOF | Cody Laboratories, Inc. (US) | 2018-07-04 | — | — | EP | claimed |
| CN-108137483-A | The synthesis of Laevomethanone Hydrochloride or the right methadone of hydrochloric acid and its application method | 科迪实验室公司 | 2018-06-08 | — | — | CN | claimed |
| WO-2017035224-A1 | SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE OR DEXTROMETHADONE HYDROCHLORIDE AND METHODS FOR USE THEREOF | CODY LABORATORIES, INC. (US) | 2017-03-02 | — | — | WO | claimed |
| US-20170057909-A1 | SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE OR DEXTROMETHADONE HYDROCHLORIDE AND METHODS FOR USE THEREOF | ALTER DOMUS (US) LLC | 2017-03-02 | — | — | US | claimed |
| US-20260131016-A1 | NOVEL AURISTATIN ANALOGS AND IMMUNOCONJUGATES THEREOF | ADCENTRX THERAPEUTICS INC (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4741406-A1 | NEUROKININ-1 RECEPTOR ANTAGONIST COMPOUND | Creadev (Nanjing) Pharmaceutical Technology Co., Ltd. (CN) | 2026-05-13 | — | — | EP | disclosed |
| US-20260103459-A1 | SUBSTITUTED AZACYLES AS TRPM8 MODULATORS | GIVAUDAN SA (CH) | 2026-04-16 | — | — | US | disclosed |
| US-20260035357-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCE INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-12528801-B2 | Substituted azacyles as TRPM8 modulators | GIVAUDAN SA (CH) | 2026-01-20 | — | — | US | disclosed |
| US-12404262-B2 | Therapeutic compounds for HIV virus infection | GILEAD SCIENCES, INC. (US) | 2025-09-02 | — | — | US | disclosed |
| WO-2008021936-A2 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-02-21 | — | — | WO | disclosed |
| WO-2008021928-A2 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-02-21 | — | — | WO | disclosed |
| US-20070299075-A1 | e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent | BRISTOL-MYERS SQUIBB COMPANY | 2007-12-27 | — | — | US | disclosed |
| US-7265113-B2 | Inhibitors of kinases | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
| US-20050124621-A1 | Novel inhibitors of kinases | BHIDE RAJEEV S (US) | 2005-06-09 | — | — | US | disclosed |
| US-6869952-B2 | Pyrrolo[2,1-f][1,2,4]triazine inhibitors of kinases | BRISTOL MYERS SQUIBB COMPANY (US) | 2005-03-22 | — | — | US | disclosed |
| US-20040072832-A1 | Novel inhibitors of kinases | BRISTOL-MYERS SQUIBB COMPANY | 2004-04-15 | — | — | US | disclosed |